Clinical correlates of the presence of the Asp816Val c-kit mutation in the peripheral blood mononuclear cells of patients with mastocytosis

Cancer

Volumn 83, Issue 10, 1998, Pages 2120-2129

  Worobec, Alexandra S ^a   Semere, Tekli ^a   Nagata, Hiroshi ^b   Metcalfe, Dean D ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

C kit; Mastocytosis; Mutation; Osteosclerosis

Indexed keywords

ASPARTIC ACID; IMMUNOGLOBULIN; RNA; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR; VALINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL FEATURE; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; INFANT; MAJOR CLINICAL STUDY; MALE; MASTOCYTOSIS; MONONUCLEAR CELL; ONCOGENE C KIT; OSTEOSCLEROSIS; PEDIGREE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RADIOGRAPHY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BONE DISEASES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LEUKOCYTES, MONONUCLEAR; MALE; MASTOCYTOSIS; MIDDLE AGED; POINT MUTATION; PROTO-ONCOGENE PROTEINS C-KIT;

EID: 0032533582     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19981115)83:10<2120::AID-CNCR10>3.0.CO;2-C     Document Type: Article

References (30)

1. Vliagoftis H, Worobec AS, Metcalfe DD. C-kit and c-kit ligand in human disease. J Allergy Clin Immunol 1997;100: 435-40.
2. Nilsson G, Metcalfe DD. Contemporary issues in mast cell biology. Allergy Asthma Proc 1996;17:59-63.
3. Kirshenbaum AS, Goff JP, Kessler SW, Mican JM, Zsebo KM, Metcalfe DD. Effect of IL-3 and stem cell factor on the appearance of human basophils and mast cells from CD34+ pluripotent progenitor cells. J Immunol 1992;148:772-7.
4. ∈RI- cell population. Blood 1994;84:2489-96.
5. Kitayama H, Kanakura Y, Furitsu T, Tsujimura T, Oritani K, Ikeda H, et al. Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines. Blood 1995;85:790-98.
6. Kitayama H, Tsujimura T, Matsumura I, Oritani K, Ikeda H, Ishikawa J, et al. Neoplastic transformation of normal hematopoietic cells by Constitutively activating mutations of c-kit receptor tyrosine kinase. Blood 1996;88:995-1004.
7. Nagata H, Worobec AS, Oh CK, Chowdhury BA, Tannenbaum S, Suzuki Y, et al. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci USA 1995;92:10560-4.
8. Longley BJ, Tyrrell L, Lu SZ, Ma YS, Langley K, Ding TG, et al. Somatic c-kit activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm. Nat Genet 1996;12:312-4.
9. Lawrence JB, Freidman BS, Travis WD, Chinchilli VM, Metcalfe DD, Gralnick HR. Hematologic manifestation of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis. Am J Med 1991;91:612-24.
10. Lichtman MA. Hematopoietic stem cell disorders: classification and manifestations. In: Williams WJ, Beutler E, Erslev AJ, Lichtman MA, editors. Hematology. 4th edition. New York: McGraw-Hill Publishing Co., 1990:148-57.
11. Horny H-P, Parwaresch MR, Lennert K. Bone marrow findings in systemic mastocytosis. Hum Pathol 1985;16:808-14.
12. Travis WD, Chin-Yang L, Bergstrath EJ, Yam LT, Swee RG. Systemic mast cell disease: analysis of 58 cases and literature review. Medicine 1991;67:345-68.
13. Worobec AS, Kirshenbaum AS, Schwartz LB, Metcalfe DD. Treatment of three patients with mastocytosis with interferon α-2b. Leuk Lymphoma 1996;22:501-8.
14. Papayannopoulou T, Brice M, Broudy VC, Zsebo KM. Isolation of c-kit receptor-expressing cells from bone marrow, peripheral blood, and fetal liver: functional properties and composite antigenic profile. Blood 1991;78:1403-12.
15. Bianchine PJ, Metcalfe DD. Systemic mastocytosis. In: Kaplan A, editor. Allergy. 2nd edition. New York: Churchill Livingstone, 1997:854-60.
16. de Gennes C, Kuntz D, de Vernejoul MC. Bone mastocytosis. Clin Orthop 1992;279:281-91.
17. Johansson C, Roupe G, Lindstedt G, Mellstrom D. Bone density, bone markers and bone radiological features in mastocytosis. Age Ageing 1996;25:1-7.
18. Chen CC, Andrich MP, Mican JM, Metcalfe DD. A retrospective analysis of bone scan abnormalities in mastocytosis: correlation with disease category and prognosis. J Nucl Med 1994;35:1471-75.
19. Gattei V, Aldinucci D, Quinn JM, Degan M, Cozzi M, Perin V, et al. Human osteoclasts and preosteoclast cells (FLG 29.1) express functional c-kit receptors and interact with osteoblast and stromal cells via membrane-bound stem cell factor. Cell Growth Differ 1996;7:753-63.
20. Lewis DB, Liggitt HD, Effmann EL, Motley ST, Teitelbaum SL, Jepsen KJ, et al. Osteoporosis induced in mice by overproduction of interleukin-4. Proc Natl Acad Sci USA 1993; 90:11618-22.
21. Gagari E, Tsai M, Lantz CS, Fox LG, Galli SJ. Differential release of mast cell interleukin-6 via c-kit. Blood 1997;89: 2654-63.
22. Bellido T, Stahl N, Farruggella TJ, Borba V, Yancopoulos GD, Manolagas SC. Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells. J Clin Invest 1996;97:431-7.
23. Goldhill J, Morris SC, Maliszewski C, Urban JF Jr., Funk CD, Finkelman FD, et al. Interleukin-4 modulates cholinergic neural control of mouse small intestinal longitudinal muscle. Am J Physiol 1997;272:G1135-40.
24. Sanders M. A case for interstitial cells of Cajal as pacemakers and mediators of neurotransmission in the gastrointestinal tract. Gastroenterology 1996;111:492-515.
25. Komuro T, Tokui K, Zhou DS. Identification of the interstitial cells of Cajal. Histol Histopathol 1996;11:769-86.
26. Bernex F, De Sepulveda P, Kress C, Elbaz C, Delouis C, Panthier JJ. Spatial and temporal patterns of c-kit expressing cells in WlacZ/+ and WlacZ/WlacZ mouse embryos. Development 1996;122:3023-33.
27. Tokutomi N, Maeda H, Tokutomi Y, Sato D, Sugita M, Nishikawa S, et al. Rhythmic C1-current and physiological roles of the intestinal c-kit positive cells. Pflugers Arch 1995;431: 169-77.
28. Isozaki K, Hirota S, Nakama A, Miyagawa J, Shinomura Y, Xu Z, et al. Disturbed intestinal movement, bile reflux to the stomach, and deficiency of c-kit expressing cells in Ws/Ws mutant rats. Gastroenterology 1995;109:456-64.
29. Pignon JM, Giraudier S, Duquesnoy P, Jouault H, Imbert M, Vainchenker W, et al. A new c-kit mutation in a case of aggressive mast cell disease. Br J Haematol 1997;96:374-6.
30. Pignon JM. C-kit mutations and mast cell disorders: a model of activating mutations of growth factor receptors. Hematol Cell Ther 1997;39:114-6.